Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...

The idea behind it seems reasonable: Insurers want to ensure treatments are medically necessary before they pay for them. But ...

Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives ...

As Secretary of State, the President’s onetime foe now offers him lavish displays of public praise—and will execute his ...

According to ‘ UOL ‘, Altemir Bernardes, 51, requested R$ 5,599 via Pix for the sale of the imported medication, a value well ...

"So many of our patients and families are entitled and treat medical staff horribly. They literally harass us. Hospitals are ...

According to the website, Altemir Bernardes, 51, requested R$ 5,599 via Pix for the sale of the imported medication, a value ...

Eisai And Nuvation Bio Enter Into Exclusive Licensing Agreement For Taletrectinib In Europe And Additional Countries Outside The U.S., China And Japan. Eisai and Nuvation Bio Enter into Exclusive ...

Precigen transitioned to a commercial stage company with the US approval of PAPZIMEOS in August 2025, the first-and-only FDA-approved treatment for adults with RRP ...

Strategic collaboration expands taletrectinib global reach with a leading oncology partnerEisai will receive exclusive development, registration and commercialization rights for taletrectinib for the ...

You try to dot every “i” and cross every “t,” but errors can slip through. Those errors could be the reason your insurance ...

First FX Super One pre-production vehicle has successfully rolled off the line at the Company's FF AI-Factory in California in December, reflecting that the FF Global Auto Industry Bridge Strategy has ...